Avisa Diagnostics Inc FOGCF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $4.40
- Market Cap
- $2.75
- Volume/Avg
- 219,979 / 75,168
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Avisa Diagnostics Inc is a clinical-stage medical device company developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company has established clinical proof-of-concept through trials in cystic fibrosis, tuberculosis and community acquired pneumonia, which demonstrated positive safety and clinical efficacy results. Avisa is planning pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia and plans to submit Investigational Device Exemption applications to the U.S. FDA for these trials.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 3
- Website
- https://www.avisapharma.com
Valuation
|
Metric
|
FOGCF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
FOGCF
Financial Strength
|
Metric
|
FOGCF
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.06 |
Interest Coverage | −6.50 |
Quick Ratio
FOGCF
Profitability
|
Metric
|
FOGCF
|
|---|---|
Return on Assets (Normalized) | −510.33% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
FOGCF
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Jvlfkyt | Hvkdw | $185.4 Bil | |
SYK
| Stryker Corp | Qdhtfszyjk | Bttq | $128.2 Bil | |
BSX
| Boston Scientific Corp | Rzjlvck | Xppfx | $107.7 Bil | |
MDT
| Medtronic PLC | Gzcjyctvr | Sbxjlz | $105.2 Bil | |
DXCM
| DexCom Inc | Dtnxhptqx | Pmtv | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Hkjhfqkbz | Bskypx | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Wmzjjgqymc | Mrymc | $24.6 Bil | |
ALGN
| Align Technology Inc | Cdkfwnkys | Kjngxlt | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Xvckhrn | Bmfjnh | $18.7 Bil | |
PODD
| Insulet Corp | Krvnwgbvk | Wjhlj | $11.5 Bil |